CL vs IDXX · P/E 34, rev $10.69B vs P/E 40, rev $2.36B
Colgate-Palmolive Company (CL) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CL currently screens at market cap $70.88B and trailing P/E 34.3. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CL and IDXX stock pages for the full models.
Not investment advice.